Webb7 jan. 2010 · As part of the agreement, bioMerieux will have access to Philips' proprietary Magnotech technology for hospital-based point-of-care testing applications. Commercial solutions resulting from the partnership will be co-branded by Philips and bioMerieux, with bioMerieux being the exclusive distributor worldwide. WebbMagnotech technology is used in Siemens' Atellica VTLi Patient-Side Immunoassay Analyzer, a test for high-sensitivity cardiac troponin I. The technology behind Magnotech was initiated by Philips Research Fellow, Menno Prins. In 2014 he became full professor …
Development of a rapid, high sensitive point-of-care test for NT ...
WebbPrimary hyperparathyroidism (PHPT) is caused by a single-gland disease in more than 80% of patients, for whom unilateral cervical exploration would be beneficial compared with a four-gland exploration [ 1 ]. The improvement in imaging with … http://www.enzyme-inhibitors.com/2016/12/07/qualifications-intraoperative-parathyroid-hormone-iopth-is-used-during-minimally-intrusive-parathyroidectomy/ income limits if collecting social security
Sensitive and rapid immunoassay for parathyroid hormone
WebbDe nieuwe Magnotech-technologie van Philips brengt in-vitro-diagnostische tests vanuit het laboratorium naar gedecentraliseerde situaties, zoals naar het bed van de patiënt en naar de thuissituatie. Magnotech heeft magnetische nanopartikels geïntegreerd in een wegwerpcartridge met biosensor, die in een draagbare analysator wordt geplaatst. WebbExceptional ultrasound. capabilities in the palm of your hand. From the ambulance to the OR and everywhere in between, Lumify handheld ultrasound helps you see your patient like never before. Buy from retailer. http://www.mtbeurope.info/news/2008/811056.htm incepcja inception